These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6547178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    Gylys JA, Wright RN, Nicolosi WD, Buyniski JP, Crenshaw RR.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF, Seymour PA, Schmidt AW, Zorn SH, Schulz DW, Lebel LA, McLean S, Guanowsky V, Howard HR, Lowe JA.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [Abstract] [Full Text] [Related]

  • 5. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM, Banerjee AK, Zhu YN, Erdmann W, Parmar SS, Salzman SK.
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
    Clineschmidt BV, McKendry MA, Papp NL, Pflueger AB, Stone CA, Totaro JA, Williams M.
    J Pharmacol Exp Ther; 1979 Mar; 208(3):460-7. PubMed ID: 34710
    [Abstract] [Full Text] [Related]

  • 8. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
    Depoortère R, Barret-Grévoz C, Bardin L, Newman-Tancredi A.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):34-8. PubMed ID: 18773888
    [Abstract] [Full Text] [Related]

  • 9. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 12; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T.
    J Pharmacol Exp Ther; 1993 Jan 12; 264(1):158-65. PubMed ID: 8093723
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS, Yablonsky-Alter E, Lidsky TI, Banerjee SP.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):181-6. PubMed ID: 18457824
    [Abstract] [Full Text] [Related]

  • 12. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY.
    Pharmacol Biochem Behav; 2005 Oct 10; 82(2):361-72. PubMed ID: 16216322
    [Abstract] [Full Text] [Related]

  • 13. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S, Lai H, Horita A.
    J Pharmacol Exp Ther; 1983 Nov 10; 227(2):383-8. PubMed ID: 6631720
    [Abstract] [Full Text] [Related]

  • 14. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 10; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep 10; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 17. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun 10; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
    Okuyama S, Chaki S, Yoshikawa R, Suzuki Y, Ogawa S, Imagawa Y, Kawashima N, Ikeda Y, Kumagai T, Nakazato A, Nagamine M, Tomisawa K.
    J Pharmacol Exp Ther; 1997 Jul 10; 282(1):56-63. PubMed ID: 9223539
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J, Koulu M, Scheinin M, Syvälahti E.
    Methods Find Exp Clin Pharmacol; 1985 Aug 10; 7(8):451-4. PubMed ID: 3935892
    [Abstract] [Full Text] [Related]

  • 20. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM, Delitala G, Grossman A, Stubbs WA, Yeo T.
    Br J Pharmacol; 1980 Aug 10; 71(2):569-73. PubMed ID: 6110459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.